Could electromagnetic waves help shrink breast tumors before surgery?

NCT ID NCT07218432

Recruiting now Disease control Sponsor: Barbara Ann Karmanos Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether a device called TheraBionic P1, which delivers targeted electromagnetic fields, can affect breast cancer tumors before surgery. About 24 women with early-stage, hormone receptor-positive, HER2-negative breast cancer will use the device three times daily for 60 minutes each session. Researchers will measure how many cancer cells remain in the removed tumor tissue to see if the treatment has any effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TheraBionic P1 device (amplitude-modulated electromagnetic fields)
What this could lead to: If it works, this could point toward a non-invasive, drug-free way to shrink breast cancer tumors before surgery.
What could go wrong: This is a very early, small pilot study with only 24 participants. It may show no effect on tumors, and the device is not a standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Her2-receptor negative breast cancer hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER STAGE I BREAST CANCER STAGE II BREAST CANCER STAGE IIIA HER2-NEGATIVE BREAST CANCER HORMONE RECEPTOR POSITIVE TUMOR

Contacts and locations

Locations

Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States
Karmanos Cancer Institute Weisberg Cancer Treatment Center
RECRUITING

Farmington Hills, Michigan, 48334, United States
Karmanos Cancer Institute at McLaren Clarkston
RECRUITING

Clarkston, Michigan, 48346, United States
Karmanos Cancer Institute at McLaren Flint
RECRUITING

Flint, Michigan, 48532, United States
Karmanos Cancer Institute at McLaren Greater Lansing
RECRUITING

Lansing, Michigan, 48910, United States
Karmanos Cancer Institute at McLaren Lapeer Region
RECRUITING

Lapeer, Michigan, 48466, United States
Karmanos Cancer Institute at McLaren Northern Michigan
RECRUITING

Petoskey, Michigan, 49770, United States
Karmanos Cancer Institute at McLaren Port Huron
RECRUITING

Port Huron, Michigan, 48060, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.